Fersisi Bacteriophage – Treatment Course (8 Boxes)
Fersisi Bacteriophage – Treatment Course (8 Boxes)
Complete 8-box course for confirmed Staphylococcal and Streptococcal infections.
Same product across the full course — optimized for continuity and predictable supply.
- 8 × identical boxes (consistent product across the course)
- Lab-tested quality & standardized production
- Worldwide shipping
- Cold storage (+2 °C to +8 °C) & handling guidance
Not sure whether Fersisi bacteriophage is right for your case?
We recommend a laboratory analysis before ordering.
Start bacteriophage analysis →
Product overview (general information)
Fersisi bacteriophage is a sterile filtrate of phage lysates specifically active against Staphylococcus and Streptococcus bacterial strains. The liquid bacteriophage is a transparent preparation with yellow to light brown coloration, distributed without prescription.
Composition & pharmacological action
Active components
- Staphylococcus phages: S. aureus, S. epidermidis (titer ≥ 10 ml)
- Streptococcus phages: S. pyogenes, S. sanguis, S. salivarius, S. agalactiae (titer ≥ 10 ml)
Inactive ingredients
- Bacteriological growth medium
- Standard sodium saline
- Chinazolin (preservative)
Pharmacological action
Fersisi bacteriophage leads to specific lysis of bacteria belonging to Staphylococci and Streptococci groups, providing targeted antibacterial action without affecting beneficial bacteria.
Activity spectrum & therapeutic applications
To be used for curative and prophylactic purposes in pyo-inflammatory and enteric infections caused by Staphylococcus and Streptococcus bacteria.
Otolaryngological diseases (ENT)
- Middle ear inflammation
- Tonsillitis, laryngitis, rhinitis
- Tracheitis, bronchitis, pneumonia
- Pleurisy
Skin infections
- Furunculosis, carbunculosis
- Abscess
- Deep infiltration and abscessing sycosis
Surgical diseases
- Abscess, wound infections
- Mastitis, osteomyelitis
- Phlegmon
Oral cavity inflammation
- Stomatitis, gingivitis
Eye diseases
- Bacterial conjunctivitis
- Secondary infections with thermal burns
Urogenital & gynecologic infections
- Urethritis, cystitis, pyelonephritis
- Endometritis
Enteric infections
- Gastroenterocolitis, cholecystitis
- Staphylococcal toxic infection
- Dysbacteriosis
Pediatric applications
- Pyo-inflammatory disease in children (including newborns)
- Prevention of postoperative infections
- Prevention of hospital infections
Dosage & usage information (informational)
The following information is provided for general informational purposes only and reflects usage descriptions supplied by the manufacturer. Dosage and application should be determined by qualified professionals based on individual circumstances.
Quick orientation: Highest effectiveness when used at disease onset and introduced directly to infection focus. Treatment duration is typically 6-10 days. Use immediately after opening and do not store opened containers.
General usage principles
- Highest effect achieved when used at the onset of disease
- Introduce directly to the infection's focus when possible
- Treatment duration: 6-10 days
- Use immediately after opening; do not store opened containers
- Visual inspection prior to use is recommended (clear liquid, no sediment)
- Before taking Fersisi bacteriophage orally, it is recommended to drink a glass of basic mineral water (or 2-3% solution of baking soda)
Common application routes (informational)
- Oral administration
- Rectal administration (enema, after stool)
- Local application using phage-soaked dressings/bandages
- Application into cavities (wound cavity, abdominal cavity, pleura, abscess cavity, nasal cavity, urinary bladder, uterus, vagina)
- Administration via catheter where applicable
- Intradermal injection for deep pyoderma
- Eye drops for conjunctivitis
Application methods by condition (manufacturer-style informational)
Local use (wounds, damaged areas):
- Apply three times daily for 3-5 days
- Quantity determined by size of damaged area
- Use phage-soaked bandage as disinfecting agent
Abscesses, pleuritis, arthritis, peritonitis:
- 50-200 ml introduced into cavity every other day
Cystitis and pyelonephritis:
- Administered by catheter and/or orally
Deep pyoderma:
- Intradermal use: 0.1-0.5 ml
- Total: 10 injections
Conjunctivitis:
- 2-3 drops per eye, 4-6 times daily
- Introduced by pipette
Neonatal omphalitis and pyoderma:
- Phage-soaked bandage applied twice daily
- Duration: 5-7 days
Intestinal diseases and dysbacteriosis:
- Administered orally and/or rectally
- Rectal administration by enema after stool
Recommended dosage overview (informational)
| Age group | Oral use / per day | Rectal use / per day |
|---|---|---|
| Infants (0–6 months) | 5 ml once daily, 30 min before feeding | 10 ml once daily |
| Infants (6–12 months) | 5 ml twice daily, 30 min before feeding | 10 ml once daily |
| Children (1–3 years) | 5 ml three times daily, 1 hour before meals | 20 ml once daily |
| Children (3–8 years) | 10 ml 2-3 times daily, 1 hour before meals | 30 ml once daily |
| Children & adults (8+ years) | 20 ml 2-3 times daily, 1 hour before meals | 40 ml once daily |
Additional notes
- Treatment should continue for 6-10 days
- Before taking Fersisi bacteriophage orally, it is recommended to drink a glass of basic mineral water (or 2-3% solution of baking soda)
- Use of bacteriophages does not exclude other therapeutic approaches
Unsure whether Fersisi bacteriophage is suitable?
We recommend a prior laboratory analysis.
Quality & safety information
Contraindications
No contraindications have been observed for Fersisi bacteriophage.
Drug interactions
The use of Fersisi bacteriophage does not exclude concomitant use of antibiotics or any other medicine.
Special precautions
- Shake ampoule before use
- The liquid must be clear without sediment
- Do not use if ampoule is damaged or liquid is cloudy
- Use immediately after opening; do not store opened containers
- Once opened, the preparation should not be saved for later use
Packaging & storage
- Formats: 5 ml ampoules
- Storage: +2 °C to +8 °C
- Shelf life: 12 months
- Distributed without prescription
Developed by:
G. Eliava Institute of Bacteriophages, Microbiology and Virology
Ready to order your full course?
Use the Add to cart button above and proceed to checkout.